Integration of Continuous Glucose Monitoring Into a BiHormonal Closed-Loop Artificial Pancreas

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

December 31, 2012

Study Completion Date

June 30, 2013

Conditions
Diabetes Mellitus
Interventions
DEVICE

Bi-hormonal (insulin and glucagon) artificial pancreas

Subjects wore a bionic pancreas consisting of a continuous glucose monitor, an insulin pump and a glucagon pump

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors
All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Juvenile Diabetes Research Foundation

OTHER

collaborator

The Leona M. and Harry B. Helmsley Charitable Trust

OTHER

lead

Boston University Charles River Campus

OTHER